Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00696202Phase 4Completed
Phase 4, open-label, single-arm trial of levonorgestrel intrauterine system in pregnancy, sponsored by Bayer. Primary endpoint: Adverse event related to the product causing a subject to withdraw, or be withdrawn, from the study at 12 months. Started Sep 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00696202.